Menu Search
Equities

Graft Polymer (UK) Plc

J4I:STU

Graft Polymer (UK) Plc

Actions
  • Price (EUR)0.002
  • Today's Change0.00 / 0.00%
  • Shares traded0.00
  • 1 Year change-95.51%
  • Beta--
Data delayed at least 15 minutes, as of May 16 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Graft Polymer (UK) Plc is a United Kingdom-based multi-sector chemical company. The principal activities of the Company and all its subsidiaries are the research, development and polymer modification technologies and polymer modification techniques. Its core business comprises polymer modification and the development of drug delivery systems. The Company offers bespoke, adapted, and tailored products for customer requests. Its products include GP impact modifiers for polyamide toughening, thermoplastic elastomers (TPE), PP-reinforced compounds, performance additives, polyvinyl chloride (PVC) products, polymeric alloys, vitrimers, wire and cable, non-woven, Halogen-free flame retardants products (HFFR), wood plastic composite board (WPC), recycling, hot melts, roto molding, block-copolymers, pipes, pet modification, porous products, anticorrosive coating, reinforced bioplastic, dispersants, nano graphene. The Company's subsidiaries include Graft Polymer IP Limited and GRAFTBIO Limited.

  • Revenue in GBP (TTM)587.00k
  • Net income in GBP-3.12m
  • Incorporated2017
  • Employees--
  • Location
    Graft Polymer (UK) PlcCentral Working VictoriaEccleston Yards 25LONDON SW1W 9NFUnited KingdomGBR
  • Websitehttps://graftpolymer.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.